Prostate Cancer Metastatic Disease

Oncology·MeSH: Disease

Prevalence

256.0 / 100K

Incidence

111.0 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Prostate Cancer Metastatic Disease?

There are 2 clinical trials targeting Prostate Cancer Metastatic Disease tracked by BioSniper.

What is the prevalence of Prostate Cancer Metastatic Disease?

The estimated prevalence of Prostate Cancer Metastatic Disease is approximately 256.0 per 100,000 population.

Deep-dive into Prostate Cancer Metastatic Disease

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Prostate Cancer Metastatic Disease — Drugs in Development & Clinical Trials | BioSniper